|
Market Closed -
Japan Exchange
12:00:00 21/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,387.00 JPY | -1.28% |
|
+1.29% | +14.05% |
| 17/08 | CLSA Starts Astellas Pharma at Accumulate with 3,000 Yen Price Target | MT |
| 10/08 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
| Market Cap | 4,33600Cr 2.73TCr 2.34TCr 2.18TCr 2TCr 3.76TCr 2,61300Cr 3.84TCr 26TCr 10TCr 1,31000Cr 10TCr 10TCr | P/E 2027 * |
11.7x | P/E 2028 * | 12.5x |
|---|---|---|---|---|---|
| Enterprise Value | 4,29400Cr 2.7TCr 2.32TCr 2.16TCr 1.98TCr 3.73TCr 2,58800Cr 3.8TCr 26TCr 9.99TCr 1,29700Cr 10TCr 9.93TCr | EV / Sales 2027 * |
1.85x | EV / Sales 2028 * | 1.82x |
| Free-Float |
98.88% | Yield 2027 * |
3.32% | Yield 2028 * | 3.43% |
Last Transcript: Astellas Pharma Inc.
| 1 day | -1.28% | ||
| 1 week | +1.29% | ||
| Current month | +8.40% | ||
| 1 month | +8.67% | ||
| 3 months | +4.78% | ||
| 6 months | -4.84% | ||
| Current year | +14.05% |
| 1 week | 2,250 |  | 2,418.5 |
| 1 month | 2,125 | | 2,418.5 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,557.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 01/06/2019 |
| Director/Board Member | 58 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.28% | +1.29% | +42.30% | +5.74% | 2.73TCr | |
| -0.07% | +2.93% | +76.40% | +127.73% | 1,10900Cr | |
| +0.04% | +2.02% | +49.50% | +55.01% | 64TCr | |
| +0.17% | +4.39% | +25.19% | +74.39% | 46TCr | |
| -0.70% | +3.35% | +39.81% | +44.32% | 37TCr | |
| -0.58% | +2.04% | +21.47% | +38.82% | 30TCr | |
| 0.00% | +4.87% | -0.25% | +12.59% | 26TCr | |
| +0.21% | +3.80% | +46.31% | +65.66% | 23TCr | |
| +1.19% | +0.29% | -17.00% | -53.13% | 20TCr | |
| +0.91% | +3.84% | +20.81% | +89.04% | 18TCr | |
| Average | -0.11% | +3.09% | +30.45% | +46.02% | 37.88TCr | |
| Weighted average by Cap. | -0.01% | +3.26% | +42.68% | +69.53% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,31500Cr 1.46TCr 1.25TCr 1.17TCr 1.07TCr 2.01TCr 1,39600Cr 2.05TCr 14TCr 5.39TCr 70TCr 5.48TCr 5.36TCr | 2,13700Cr 1.35TCr 1.15TCr 1.08TCr 986.49Cr 1.85TCr 1,28800Cr 1.89TCr 13TCr 4.97TCr 65TCr 5.05TCr 4.94TCr |
| Net income | 36TCr 224.14Cr 191.91Cr 179.05Cr 164.3Cr 308.72Cr 21TCr 314.8Cr 2.12TCr 828.03Cr 11TCr 841.59Cr 823.28Cr | 33TCr 209.48Cr 179.35Cr 167.34Cr 153.55Cr 288.53Cr 20TCr 294.21Cr 1.99TCr 773.87Cr 10TCr 786.55Cr 769.43Cr |
| Net Debt | -4.19TCr -26Cr -23Cr -21Cr -19Cr -36Cr -2.52TCr -37Cr -249.96Cr -97Cr -1.26TCr -99Cr -97Cr | -44TCr -276.57Cr -236.8Cr -220.94Cr -202.73Cr -380.94Cr -26TCr -388.44Cr -2.62TCr -1.02TCr -13TCr -1.04TCr -1.02TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | JP¥2,387.00 | -1.28% | 45,64,900 |
| 20/26/20 | JP¥2,418.00 | +3.47% | 70,92,700 |
| 19/26/19 | JP¥2,337.00 | +1.15% | 83,54,700 |
| 18/26/18 | JP¥2,310.50 | +1.20% | 48,08,500 |
| 17/26/17 | JP¥2,283.00 | -3.12% | 39,04,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
